SRT-1720

DB17057ExperimentalSmall molecule

SRT-1720 is an activator of NAD(+)-dependent histone deacetylase SIRT1.

Chemical structure of SRT-1720
Formula / weight
C25H23N7OS · 469.57 g/mol (avg)
Also known as
2-quinoxalinecarboxamide, n-(2-(3-(1-piperazinylmethyl)imidazo(2,1-b)thiazol-6-yl)phenyl)- · N-(2-(3-(1-piperazinylmethyl)imidazo(2,1-b)thiazol-6-yl)phenyl)-2-quinoxalinecarboxamide
Code names
SRT-1720

Resolves to

Compound
UNIIDX3FHY76FZCAS925434-55-5ChEMBLCHEMBL257991
Structure
InChIKeyIASPBORHOMBZMY-UHFFFAOYSA-NSMILESO=C(NC1=C(C=CC=C1)C1=CN2C(CN3CCNCC3)=CSC2=N1)C1=CN=C2C=CC=CC2=N1
Targets
Q96EB6SIRT1

What you can answer from here — as of March 06, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with SRT-1720, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In